science
informative
Pfizer's mRNA flu vaccine shows superior results in clinical trial
Nov 19, 2025, 11:02 PM10
(Update: Nov 19, 2025, 11:02 PM)
science
informative
Pfizer's mRNA flu vaccine shows superior results in clinical trial
- In a Phase 3 trial, over 18,000 adults received either Pfizer's mRNA flu vaccine or a standard flu shot during the 2022-2023 flu season.
- The mRNA vaccine showed approximately 27% higher efficacy than the traditional flu vaccine, although it also resulted in more side effects.
- These findings indicate the mRNA shot's potential as a new approach for influenza prevention.
Insights
News 1 1
Related reports
Opinions
Story
“
trends policy trends shift insight strategic strategic data analysis market policy trends insight analysis trends geopolitical policy trends policy impact strategic data market policy trends data impact global shift insight data global global global data data economic insight policy analysis global trends trends shift trends geopolitical market economic trends policy strategic policy analysis shift global shift analysis market strategic trends analysis strategic economic economic impact data strategic analysis strategic global insight policy trends policy policy shift shift economic economic impact...
2026 All rights reserved
2026 All rights reserved